✦ LIBER ✦

Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports

✍ Scribed by R Andrew Moore, Sheena Derry, Geoffrey T Makinson…

Book ID: 120707326
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 724 KB
Volume: 7
Category: Article
ISSN: 1478-6354
DOI: 10.1186/ar1704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correction: Tolerability and adverse eve

Correction: Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports

✍ R Andrew Moore, Sheena Derry, Geoffrey T Makinson… 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 24 KB

Adalimumab in rheumatoid arthritis treat

Adalimumab in rheumatoid arthritis treatment: a systematic review and meta-analysis of randomized clinical trials

✍ Ávila Machado, Marina Amaral de; Maciel, Alessandra Almeida; Pires de Lemos, Lív 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 Portuguese ⚖ 284 KB

Erratum of “Adalimumab in rheumatoid art

Erratum of “Adalimumab in rheumatoid arthritis treatments: a systematic review and meta-analysis of randomized clinical trials”

✍ Machado, Marina Amaral de Ávila; Maciel, Alessandra Almeida; Lemos, Lívia Lovato 📂 Article 📅 2014 🏛 Springer (Biomed Central Ltd.) 🌐 Portuguese ⚖ 159 KB

Adverse event assessment, analysis, and

Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations

✍ Smith, Shannon M.; Wang, Anthony T.; Katz, Nathaniel P.; McDermott, Michael P.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Time for changes in the design, analysis

Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials

✍ David T. Felson; Jennifer J. Anderson; Robert F. Meenan 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 910 KB

The randomized, controlled clinical trial has become the standard approach to evaluating the efficacy of slow-acting drugs in the treatment of rheumatoid arthritis (RA). Such trials, which were used as far back as the 1940s to evaluate antimalarial agents and gold and as recently as 1988 to evaluate

Systematic review and meta-analysis of a

Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials

✍ K.R. McQuaid; L. Laine 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 43 KB